Delivery Order SPE2DB20D3505-SPE2DB23FT6B8
- Not listed
- This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ZAFEMY 150-35 MCG/DAY PATCH 3S, a medical product, with a ceiling value of $2,656.15 and a completion date of June 27, 2025. The contract is a firm fixed-price arrangement and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,405.32, is for the supply of the drug ZAFEMY 150-35 MCG/DAY PATCH 3S. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,524.17 firm fixed-price contract is for the delivery of ZAFEMY 150-35 MCG/DAY PATCH 3S, a medical product, with a completion date of June 10, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp is the prime contractor and there are no major...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ZAFEMY 150-35 MCG/DAY PATCH 3S. The contract has a firm fixed price of $1,797.48 and an ultimate completion date of June 25, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,753.71, is for the delivery of ZAFEMY 150-35 MCG/DAY PATCH 3S, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of Zafemy 150-35 mcg/day patch, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $2,155.98. The contract is a delivery order with a firm fixed price pricing type and has an ultimate completion date of September 13, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,199.40, is for the provision of a specialty medication patch product, ZAFEMY 150-35 MCG/DAY PATCH 3S. The contract has a firm fixed price and is set to expire on April 10, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of 4565436076 ! ZAFEMY 150-35 MCG/DAY PATCH 3S. The total ceiling value of the delivery order is $13,152.84. The contract is a firm fixed-price arrangement with an ultimate completion date of August 14, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by various defense and...
- This delivery order, valued at $3,150.48, awards pharmaceutical supplies to AmerisourceBergen Drug Corp for the Defense Logistics Agency (DLA). The contract covers ZAFEMY 150-35 mcg/day patches (a three-unit quantity), with a firm fixed price structure and no set-aside designation. The award was issued on November 12, 2025, with an ultimate completion date of November 13, 2025, and performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZAFEMY 150-35 MCG/DAY PATCH 3S, a pharmaceutical product. The delivery order has a firm fixed price of $5,437.22 and a period of performance extending to June 11, 2025. This award is not associated with a set-aside program. The contract is part of Amerisourcebergen Drug...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FT6B8Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,362.60 delivery order is for the supply of the medication ZAFEMY 150-35 MCG/DAY PATCH 3S and has a completion date of January 26, 2023. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., has a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, covering similar medical products and prescription drugs. These IDCs demonstrate Amerisourcebergen's capacity to meet the diverse and critical pharmaceutical needs of multiple government agencies on a large scale.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/25/23 |